Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20170623004
TCTR20170623004
Completed
Phase 2

Efficacy and tolerability of two quadruple regimens;bismuth,omeprazole, metronidazole and Amoxicillin or tetracycline as first line treatment for eradication of helicobacter pylori in patients with duodenal ulcer

Shahid Sadoughi University of Medical Sciences0 sites228 target enrollmentJune 23, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionseradicationdrug resistancehelicobacter pyloriQuadruple therapyeradicationdrug resistancehelicobacter pyloriQuadruple therapy

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
eradication
Sponsor
Shahid Sadoughi University of Medical Sciences
Enrollment
228
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 23, 2017
End Date
July 1, 2016
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Shahid Sadoughi University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Patients were eligible if they were aged
  • •18 years or older and had confirmed H pylori infection. H
  • •pylori infection was diagnosed by either a positive rapid urease
  • •test or positive identification of H pylori in a histological sample
  • •using haematoxylin and eosin and/or Giemsa stain

Exclusion Criteria

  • •were excluded if they had any of the followings: previous eradication
  • •therapy for H pylori; known allergies to any of the study
  • •medications; recent use of antibiotics, bismuth salts, probiotic
  • •preparations, proton pump inhibitors or non\-steroidal antiinflammatory
  • •drugs in the preceding 1 month; pregnant or lactating
  • •women; previous gastric surgery; alcohol or drug abuse;
  • •or severe concurrent medical illnesses, such as liver failure, renal
  • •failure or terminal malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
A comparison between triple and quadruple therapy efficacy in eradication of Helicobacter pylori in patients with dyspepsiaHelicobacter Pylori.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
IRCT2016012623736N2orestan University of Medical Sciences321
Recruiting
Phase 4
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori EradicationHELICOBACTER PYLORI INFECTIONS
NCT06723197Shandong University330
Completed
Phase 4
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in EgyptiansH.Pylori Infection
NCT06315478Helwan University60
Not yet recruiting
Phase 2
Investigating the effect of furazolidone drug for the treatment of stomach bacterial infectioH. pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
IRCT20230202057305N1Shahid Beheshti University of Medical Sciences135
Completed
Phase 1
Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202Parkinson's Disease
NCT02772627Bial - Portela C S.A.22